Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on ...

Abbott Laboratories gains attention as medical devices, diabetes care, cardiovascular products, and raised guidance ...

Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for the Alinity i laboratory traumatic brain injury (TBI) blood test. This will be the first commercially available TBI ...

Two years after Abbott landed FDA clearance for a hand-held blood test that could detect signs of mild traumatic brain injuries (TBIs) in the span of about 15 minutes, the concussion-spotting test is ...

(Reuters) - The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories’ speedy coronavirus test, which can deliver results within minutes and is used at the White House, could ...

Shares of Abbott Laboratories popped after the company's earnings and revenue topped Wall Street estimates, defying a dramatic slowdown in sales of its Covid tests. The results were driven in part to ...

A new study suggests that the Covid-19 diagnostic test being used by the White House frequently misses cases of the virus. The Abbott ID NOW test, which has been touted by President Trump on several ...

The healthcare company said its profit fell to $928 million, or 53 cents a share, in the second quarter, from $1.78 billion, ...

Abbott’s valuation debate sharpens as legal pressure eases and medical devices, diagnostics, earnings quality, and future cash generation support its outlook.

Abbott (ABT) reports Q2 earnings July 15; see EPS/revenue forecasts, analyst outlook on Exact Sciences MCED test, and what to ...